ENZO BIOCHEM INC (Stock Symbol: ENZB)
is a leading company in the Life Sciences sector
, specifically operating within the Biological Products, (No Diagnostic Substances) industry.
.
The company has established itself as
an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Annual Revenue: $27 million
generating a -17.5% net profit margin
.
Market Capitalization: $37 million - Classified as a
small-cap investment offering high growth potential.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for ENZO BIOCHEM INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
ENZO BIOCHEM INC strategically competes in the highly dynamic
Biological Products, (No Diagnostic Substances) marketplace,
representing an emerging small-cap investment with substantial growth potential and market disruption capabilities
.
.
ENZO BIOCHEM INC Stock Price Chart and Technical Analysis
Loading chart data...
Loading ENZO BIOCHEM INC interactive price chart and technical analysis...
Deep dive into ENZO BIOCHEM INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.
Understanding Valuation Metrics
What these metrics mean: Valuation metrics help determine if ENZO BIOCHEM INC stock is fairly priced compared to its earnings, assets, and market position.
How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.
For ENZO BIOCHEM INC:
P/B Ratio0.84x
Market Cap$37M
EPS$-0.41
Book Value/Share$0.83
Revenue/Share$0.52
Understanding Profitability Metrics
What these metrics mean: These ratios measure how efficiently ENZO BIOCHEM INC converts revenue into profit and generates returns for shareholders.
How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.
For ENZO BIOCHEM INC:
Operating Margin-16.9%
Net Margin-17.5%
Understanding Financial Health Metrics
What these metrics mean: These ratios assess ENZO BIOCHEM INC's ability to meet short-term obligations and manage debt levels effectively.
How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.
For ENZO BIOCHEM INC:
Understanding Cash Flow Metrics
What these metrics mean: Cash flow metrics reveal ENZO BIOCHEM INC's ability to generate cash from operations and fund growth initiatives.
How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.
For ENZO BIOCHEM INC:
Understanding Operational Efficiency Metrics
What these metrics mean: These ratios measure how effectively ENZO BIOCHEM INC uses its assets and manages working capital.
How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.
For ENZO BIOCHEM INC:
Understanding Financial Statement Data
What these metrics mean: Key figures from ENZO BIOCHEM INC's income statement and balance sheet showing absolute financial performance.
How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.
For ENZO BIOCHEM INC: With annual revenue of $27M, ENZO BIOCHEM INC represents a smaller but potentially high-growth operation.
Income Statement ($ Millions)
Total Revenue$27M
Operating Income$-17M
Net Income$-17M
R&D Expense$7M
Balance Sheet Highlights ($ Millions)
Dividend & Shareholder Information
Shares Outstanding52M
ENZO BIOCHEM INC (ENZB) Fundamental Analysis & Insider Trading Data
(Quarterly Financial Reports)
Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for ENZO BIOCHEM INC stock analysis.
Loading fundamental data...
Loading ENZO BIOCHEM INC comprehensive fundamental analysis and insider trading data...
Enzo Biochem Inc in Farmingdale, LI, begins building sales force of its own after terminating contract with Affymetrix, its principal distributor, and filing lawsuit accusing it of improperly ...
Enzo Biochem, Inc. announced its financial results for the fiscal second quarter ending January 31, 2025, highlighting improvements in revenue, gross margin, and operating profit.
Enzo Biochem, Inc. announced its financial results for the first quarter of the fiscal year ending October 31, 2024, reporting revenues of $6.2 million, a 20% decline from the previous year ...
Farmingdale, NY, June 24, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (ENZB) (“Enzo” or the “Company”) today announced that on June 23, 2025, following the market close, it entered into an ...
Enzo Biochem, Inc. (NYSE:ENZ) today announced that on May 7, 2019 it was issued U.S. Patent No. 10,278,960 entitled “Sphingosine Pathway Modulating Co ...
For Enzo Biochem: For Media: For Investors: Patricia Eckert, Interim CFO 631-755-5500 Lynn Granito Berry & Company Public Relations 212-253-8881 Chris Calabrese LifeSci Advisors, LLC 917-680-5608 and ...
FARMINGDALE, NY, July 24, 2023 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) today announced that it has closed a transaction to sell certain assets of Enzo’s Clinical laboratory division ...
Conference Call and Webcast Scheduled for December 13th, 8:30 AM ET New York, NY, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostics company ...
Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostics and therapeutics company, today announced the issuance of U.S. Patent No. 10,323,272 entitled ...
Information about the directors and executive officers of Enzo is set forth in its Annual Report on Form 10-K for the fiscal year ended July 31, 2024, which was filed with the SEC on October 29 ...
Comparative analysis of ENZO BIOCHEM INC against industry peers and competitors in the Life Sciences sector, featuring AI-powered forecasts and key financial metrics.
How accurate are ENZO BIOCHEM INC stock predictions?
Our AI model demonstrates 49% historical accuracy for ENZB predictions, based on advanced machine learning algorithms trained on over 10 years of market data.
What factors influence ENZO BIOCHEM INC stock price forecasts?
Based on our AI analysis, ENZO BIOCHEM INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.
How often are ENZO BIOCHEM INC forecasts updated?
ENZO BIOCHEM INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.
Want More Advanced ENZO BIOCHEM INC Analysis?
Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for ENZO BIOCHEM INC stock.
